5mg/1ml semaglutide 5mg — Selective GLP-1 Receptor Agonist — Research Peptide – Prime Labs 99.00 | Semaglutide with B-12

Compounding is allowed when: Patient-Specific Needs: Compounded medications are created based on a prescription for an individual patient, often because commercially available drugs don't meet specific needs (e.g., different dosage, allergen-free formulation)

These are typical mean (average) results

It is supposed to be small

This equalizes the pressure, making the water addition smooth and controlled

This could explain why tirzepatide (which stimulates the GIP pathway in addition to GLP -1) can be administered at higher doses than semaglutide (which only stimulates GLP-1), without amplifying the side effects typical of GLP-1 agonists (nausea, vomiting)